GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » Short Ratio

Decision Diagnostics (Decision Diagnostics) Short Ratio


View and export this data going back to . Start your Free Trial

What is Decision Diagnostics Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Decision Diagnostics (Decision Diagnostics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » Short Ratio
Comparable Companies
JSE:AMS JSE:NPH JSE:THA JSE:GML JSE:RBP WBA BSP:RADL3 SAU:4164 HKSE:00241 TSE:3088 SHSE:603939 TSE:3141 TSE:3349 JSE:CLS SHSE:600998 TSE:9989 TSE:3391 TSE:7649 SHSE:603883 SZSE:002727
Traded in Other Exchanges
N/A
Address
2660 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361
Website
http://www.decisiondiagnostics.co
Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.
Executives
Keith Berman director, officer: Secretary 2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
Robert Jagunich director 765 CHRISTINE DR PALO ALTO CA 94303
Robert Lawrence Cox director, officer: President

Decision Diagnostics (Decision Diagnostics) Headlines

From GuruFocus

BREAKING NEWS: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Decision Diagnostics Corp. Investors with Large Losses to Secure Counsel Before Important Deadline - DECN

By PRNewswire PRNewswire • 02-04-2021

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN

By PRNewswire PRNewswire • 01-31-2021

DECN Secures Exclusive Distributor Agreement With a German Based Company for the Distribution of Genviro! Covid-19 :10 Saliva Testing Kits and Meters in 18 EU Countries, Norway and the UK

By ACCESSWIRE ACCESSWIRE • 12-10-2020

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Decision Diagnostics Corp.; Encourages Investors with Losses in Excess of $500K to Contact the Firm � DECN

By Marketwired Marketwired • 01-25-2021

DECISION DIAGNOSTICS CORP. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces the filing of a federal securities class action lawsuit against Decision Diagnostics Corp.

By PRNewswire PRNewswire • 01-22-2021

ROSEN, A LEADING LAW FIRM, Encourages Decision Diagnostics Corp. Investors With Losses in Excess of $500K to Secure Counsel Before Important March 16 Deadline � DECN

By Marketwired Marketwired • 03-03-2021

DECISION DIAGNOSTICS CORP. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a federal securities class action lawsuit has been filed against Decision Diagnostics Corp.

By Marketwired Marketwired • 03-04-2021

ROSEN, A LEADING LAW FIRM, Encourages Decision Diagnostics Corp. Investors with Losses In Excess of $100K to Secure Counsel Before Important Deadline � DECN

By Marketwired Marketwired • 02-14-2021

DECN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Decision Diagnostics Corp. Investors of Class Action and Encourages Shareholders to Contact the Firm

By PRNewswire PRNewswire • 01-19-2021

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Decision Diagnostics Corp. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

By PRNewswire PRNewswire • 02-17-2021